Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1700057	重组全人源抗肿瘤坏死因子-α单克隆抗体注射液	adalimumab	Injection	Biological Products(2)	New Drug Application	2017-07-20	上海华奥泰生物药业有限公司	Shanghai Huaota Biopharmaceutical Co Ltd	Certificate Issued	2018-06-28	view
CXSL1600104	重组人源化抗血管内皮生长因子(VEGF)单克隆抗体注射液		Injection	Biological Products(2)	New Drug Application	2017-02-13	上海华奥泰生物药业有限公司	Shanghai Huaota Biopharmaceutical Co Ltd	Certificate Issued	2018-08-27	view
CXSL1500080	重组全人源抗肿瘤坏死因子-α单克隆抗体注射液	adalimumab	Injection	Biological Products(2)	New Drug Application	2015-10-19	上海华奥泰生物药业有限公司	Shanghai Huaota Biopharmaceutical Co Ltd	Certificate Issued	2016-12-30	view